Skip to main content
SpringerLink
Log in

Fresh from the biologic pipeline

  • News Feature
  • Published:

From Nature Biotechnology

View current issue Submit your manuscript

Randy Osborne reports on the latest product approvals.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Figure 1
Figure 2: FDA approvals since 2004 according to therapeutic indication.

Author information

Authors and Affiliations

  1. Mill Valley, Calif

    Randall Osborne

Authors
  1. Randall Osborne
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Osborne, R. Fresh from the biologic pipeline. Nat Biotechnol 27, 222–225 (2009). https://doi.org/10.1038/nbt0309-222

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/nbt0309-222

  • Springer Nature America, Inc.

This article is cited by

Search

Navigation